AISLING CAPITAL MANAGEMENT LP

Adviser information for AISLING CAPITAL MANAGEMENT LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 12
Investment Advisory/Research 8
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 3 $515.7M
Non-Discretionary 0 $0
Total 3 $515.7M

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 2 $510.6M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 1 $5.1M
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 0

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-106625
SEC ERA File Number 801-106625
SEC CIK Numbers 1766721
SEC CRD Numbers 269994
Legal Entity Identifier None

Principal Office

489 FIFTH AVENUE
10TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 212-651-6380, Fax: None

Chief Compliance Officer

ROBERT WENZEL
CHIEF FINANCIAL OFFICER
489 FIFTH AVENUE
10TH FLOOR
NEW YORK
NY
United States
Tel: 212-651-6374
(Full email address available in API data)

Regulatory Contact

CAROL ZIKOPOULOS
HEAD OF HR/COMPLIANCE MANAGER
489 FIFTH AVENUE
10TH FLOOR
NEW YORK
NY
United States
Tel: 212-651-6382
(Full email address available in API data)

Industry Affiliates

AISLING CAPITAL LLC Other investment adviser, including financial planners
AISLING CAPITAL PARTNERS IV, LP Sponsor, GP, manager of pooled investment vehicles
AISLING CAPITAL PARTNERS V, LP Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
AISLING CAPITAL IV, LP Private Equity Fund $317.2M $5.0M 24
AISLING CAPITAL V, LP Private Equity Fund $193.5M $5.0M 39

Control Persons

Name Type Entity Title Since Ownership
SCHIFF, ANDREW, NEWMAN Individual CO-PRESIDENT 08/2015 50-75%
SCHIFF, ANDREW, NEWMAN Individual AISLING CAPITAL PARTNERS IV LLC MEMBER 08/2015 50-75%
ELMS, STEVEN, ARNOTE Individual CO-PRESIDENT 08/2015 50-75%
WENZEL, ROBERT, JOHN Individual CHIEF COMPLIANCE OFFICER / CHIEF FINANCIAL OFFICER 04/2017 < 5%
AISLING CAPITAL PARTNERS IV LLC Domestic Entity GENERAL PARTNER 08/2015 < 5%
ELMS, STEVEN, ARNOTE Individual AISLING CAPITAL PARTNERS IV LLC MEMBER 08/2015 50-75%

No. Employees, Historic

20100201920202021202220232024202514 on 7/31/201913 on 3/30/202014 on 3/30/202114 on 3/31/202212 on 3/30/202312 on 7/17/202312 on 3/28/2024

RAUM, Historic

800M400M02019202020212022202320242025256892170 on 7/31/2019431630100 on 3/30/2020789335087 on 3/30/2021494257919 on 3/31/2022332674494 on 3/30/2023332674494 on 7/17/2023515733599 on 3/28/2024

No. Clients, Historic

105020192020202120222023202420251 on 7/31/20192 on 3/30/20202 on 3/30/20212 on 3/31/20223 on 3/30/20233 on 7/17/20233 on 3/28/2024

Holdings

From latest 13F, filed August 8th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
Aclaris Therapeutics Inc (ACRS) COM 478K 434K
Biomea Fusion Inc (BMEA) COM 4M 799K
BridgeBio Pharma Inc. (BBIO) COM 154M 6M
CalciMedica, Inc. (CALC) COM NEW 2M 521K
Compass Pathways Plc (CMPS) SPONSORED ADS 6M 965K
Elevation Oncology Inc (ELEV) COM 8M 3M
Marker Therapeutics, Inc. (MRKR) COM NEW 2M 314K
Monte Rosa Therapeutics Inc (GLUE) COM 6M 1M
Nuvation Bio Inc. (NUVB) COM CL A 7M 3M
Poseida Therapeutics Inc. (PSTX) COM 3M 1M
Reneo Pharmaceuticals Inc (RPHM) COM 1M 886K
Syndax Pharmaceuticals, Inc. (SNDX) COM 21M 1M
Tectonic Therapeutic Inc (TECX) COM 1M 84K
Verona Pharma plc (VRNA) SPONSORED ADS 16M 1M
Viracta Therapeutics Inc (VIRX) COM 157K 289K